Aliskiren- blood pressure drug

There are currently seven classes of drugs used to reduce blood pressure. Aliskiren (Tekturna and Rasilez) is the first of a new class of orally active antihypertensive drugs that works by inhibiting the enzyme rennin that can raise blood pressure.
a review of six large-scale clinical trials of aliskiren found- the drug has not been any more effective than those already widely available to control hypertension.
In analyzing clinical trials involving more than 5,000 hypertensive patients, aliskiren was no more effective as an anti-hypertensive agent than converting enzyme inhibitors, angiotensin receptor blockers or diuretics.

The research is detailed in the May issue of the American Journal of Hypertension.